Literature DB >> 11138935

Case studies in cholera: lessons in medical history and science.

S M Kavic1, E J Frehm, A S Segal.   

Abstract

Cholera, a prototypical secretory diarrheal disease, is an ancient scourge that has both wrought great suffering and taught many valuable lessons, from basic sanitation to molecular signal transduction. Victims experience the voluminous loss of bicarbonate-rich isotonic saline at a rate that may lead to hypovolemic shock, metabolic acidosis, and death within afew hours. Intravenous solution therapy as we know it was first developed in an attempt to provide life-saving volume replacement for cholera patients. Breakthroughs in epithelial membrane transport physiology, such as the discovery of sugar and salt cotransport, have paved the way for oral replacement therapy in areas of the world where intravenous replacement is not readily available. In addition, the discovery of the cholera toxin has yielded vital information about toxigenic infectious diseases, providing a framework in which to study fundamental elements of intracellular signal transduction pathways, such as G-proteins. Cholera may even shed light on the evolution and pathophysiology of cystic fibrosis, the most commonly inherited disease among Caucasians. The goal of this paper is to review, using case studies, some of the lessons learned from cholera throughout the ages, acknowledging those pioneers whose seminal work led to our understanding of many basic concepts in medical epidemiology, microbiology, physiology, and therapeutics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11138935      PMCID: PMC2579035     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  74 in total

1.  Glucose-stimulated sodium transport by the human intestine during experimental cholera.

Authors:  L R Schiller; C A Santa Ana; J Porter; J S Fordtran
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  A 9 A two-dimensional projected structure of cholera toxin B-subunit-GM1 complexes determined by electron crystallography.

Authors:  G Mosser; V Mallouh; A Brisson
Journal:  J Mol Biol       Date:  1992-07-05       Impact factor: 5.469

3.  Reconstitution of catecholamine-sensitive adenylate cyclase activity: interactions of solubilized components with receptor-replete membranes.

Authors:  E M Ross; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

4.  Origin of the enzymatically active A1 fragment of cholera toxin.

Authors:  D M Gill; R S Rappaport
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

5.  Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group.

Authors:  N H Alam; R N Majumder; G J Fuchs
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

6.  Functional homology between signal-coupling proteins. Cholera toxin inactivates the GTPase activity of transducin.

Authors:  M E Abood; J B Hurley; M C Pappone; H R Bourne; L Stryer
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

7.  Release of guanyl nucleotides from the regulatory subunit of adenylate cyclase.

Authors:  D L Burns; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

8.  Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette.

Authors:  M Trucksis; J E Galen; J Michalski; A Fasano; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  The three-dimensional crystal structure of cholera toxin.

Authors:  R G Zhang; D L Scott; M L Westbrook; S Nance; B D Spangler; G G Shipley; E M Westbrook
Journal:  J Mol Biol       Date:  1995-08-25       Impact factor: 5.469

View more
  4 in total

1.  Volume depletion versus dehydration: how understanding the difference can guide therapy.

Authors:  Gautam Bhave; Eric G Neilson
Journal:  Am J Kidney Dis       Date:  2011-06-25       Impact factor: 8.860

2.  Known genetic susceptibility factors for chronic pancreatitis in patients of European ancestry are rare in patients of African ancestry.

Authors:  Anna Evans Phillips; Jessica LaRusch; Phil Greer; Judah Abberbock; Samer Alkaade; Stephen T Amann; Michelle A Anderson; John Baillie; Peter A Banks; Randall E Brand; Darwin Conwell; Gregory A Coté; Christopher E Forsmark; Timothy B Gardner; Andres Gelrud; Nalini Guda; Michele Lewis; Mary E Money; Thiruvengadam Muniraj; Bimaljit S Sandhu; Stuart Sherman; Vikesh K Singh; Adam Slivka; Gong Tang; C Mel Wilcox; David C Whitcomb; Dhiraj Yadav
Journal:  Pancreatology       Date:  2018-05-19       Impact factor: 3.996

3.  Human ATP-binding cassette (ABC) transporter family.

Authors:  Vasilis Vasiliou; Konstandinos Vasiliou; Daniel W Nebert
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

Review 4.  Using Electrolyte Free Water Balance to Rationalize and Treat Dysnatremias.

Authors:  Sanjeev R Shah; Gautam Bhave
Journal:  Front Med (Lausanne)       Date:  2018-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.